Federica Liotti - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Federica Liotti

Showing results (21-30 of 24) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 24 results.

Journal of Experimental & Clinical Cancer Research : CR|January 8, 2021

PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2/Ras/MAPK signalling in thyroid cancer cellsFederica Liotti, Narender Kumar, Nella Prevete, et al.

Cancers|June 12, 2019

AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid CancerFrancesca Collina, Lucia La Sala, Federica Liotti, et al.

Oncotarget|May 13, 2015

AXL is an oncotarget in human colorectal cancerErika Martinelli, Giulia Martini, Claudia Cardone, et al.

Journal for Immunotherapy of Cancer|March 5, 2022

In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapiesCaterina Ieranò, Dario Righelli, Crescenzo D'Alterio, et al.

Pageof 3

Search research articles

Showing results (21-30 of 24) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 24 results.

Journal of Experimental & Clinical Cancer Research : CR|January 8, 2021

PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2/Ras/MAPK signalling in thyroid cancer cellsFederica Liotti, Narender Kumar, Nella Prevete, et al.

Cancers|June 12, 2019

AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid CancerFrancesca Collina, Lucia La Sala, Federica Liotti, et al.

Oncotarget|May 13, 2015

AXL is an oncotarget in human colorectal cancerErika Martinelli, Giulia Martini, Claudia Cardone, et al.

Journal for Immunotherapy of Cancer|March 5, 2022

In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapiesCaterina Ieranò, Dario Righelli, Crescenzo D'Alterio, et al.

Pageof 3